FR-234938

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C19H21N3O2
Molecular Weight	323.3889
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@H](O)[C@@H](CCC1=C2C=CC=CC2=CC=C1)N3C=NC(=C3)C(N)=O

InChI

InChIKey=OODDZQQDDOVCFD-SCLBCKFNSA-N

InChI=1S/C19H21N3O2/c1-13(23)18(22-11-17(19(20)24)21-12-22)10-9-15-7-4-6-14-5-2-3-8-16(14)15/h2-8,11-13,18,23H,9-10H2,1H3,(H2,20,24)/t13-,18+/m0/s1

HIDE SMILES / InChI

Molecular Formula	C19H21N3O2
Molecular Weight	323.3889
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

PubMed

Title	Date	PubMed
Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors.	2004 May 20	15139750

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 08:55:27 UTC 2023` Edited by `admin` on `Sat Dec 16 08:55:27 UTC 2023`
Record UNII	10302WQ21V
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FR-234938

Common Name

English

1H-IMIDAZOLE-4-CARBOXAMIDE, 1-((1R,2S)-2-HYDROXY-1-(2-(1-NAPHTHALENYL)ETHYL)PROPYL)-

Systematic Name

English

(+)-FR-234938

Common Name

English

Code System Code Type Description

DRUG BANK

DB03220

Created by admin on Sat Dec 16 08:55:27 UTC 2023 , Edited by admin on Sat Dec 16 08:55:27 UTC 2023

PRIMARY

CAS

256461-79-7

Created by admin on Sat Dec 16 08:55:27 UTC 2023 , Edited by admin on Sat Dec 16 08:55:27 UTC 2023

PRIMARY

FDA UNII

10302WQ21V

Created by admin on Sat Dec 16 08:55:27 UTC 2023 , Edited by admin on Sat Dec 16 08:55:27 UTC 2023

PRIMARY

PUBCHEM

449013

Created by admin on Sat Dec 16 08:55:27 UTC 2023 , Edited by admin on Sat Dec 16 08:55:27 UTC 2023

PRIMARY

Related Record Type Details


					10302WQ21V

FR-234938

ACTIVE MOIETY